M-CSF levels may constitute a useful biomarker for a number of types of cancer, as it is expressed at high levels in a number of types of cancer, including breast cancer, ovarian cancer and colorectal carcinoma and its expression correlates with a poor prognosis (12). Here, CSF1 is linked to breast carcinoma.